INC Research Strengthens Asia/Pacific Capabilities Through Two New Offices in Japan
(Thomson Reuters ONE) -
Offices in Osaka and Shinagawa in Tokyo provide strong clinical development hub
for customers in world's second largest pharmaceutical market
Raleigh, NC, July 29, 2013 - INC Research LLC, a therapeutically focused global
clinical research organization (CRO) with a Trusted Process® for delivering
reliable results, today announced the establishment of INC Research Japan KK
with the opening of new locations in Osaka and the Shinagawa ward in Tokyo. The
new operations provide INC Research's global drug development customers access
to an increasingly significant market and further expand the Company's presence
in the Asia/Pacific region. INC Research now has 20 offices in key locations
across the Asia/Pacific region in addition to Japan, including a presence in
China, India, Australia, Singapore, Philippines, South Korea, Taiwan, Hong Kong,
Malaysia, Thailand, Indonesia and New Zealand.
"There is a growing enthusiasm from both pharma and government sectors for Japan
to be involved in both global and regional clinical trials," said Garth Tierney
, Executive Vice President, Asia/Pacific. "In response, INC Research is
implementing a very considered approach to the market that will create greater
confidence among our customers in conducting trials in Japan, as well as
ultimately provide more direct influence on how trials are conducted. Our
Japanese customers already have responded positively to our Trusted Process
methodology as it fits well with their requirements for high quality and
predictability. We are very enthusiastic about bringing the continued benefits
of drug development in this country to our customers."
Through INC Research's unique approach to the Japan market, the two offices
initially will feature a core group of highly qualified, English-speaking
management, regulatory and therapeutic staff who will create a bridge between
the Company's Trusted Process methodology and the way clinical research has
traditionally been conducted in Japan. The establishment of Japanese business
operations builds on INC Research's long-term experience in Japan where it has
partnered with local CROs to conduct numerous trials across a variety of
therapeutic areas.
The Osaka office is located at Level 19 Hilton Plaza West Office Tower, 2-2-2
UMEDA, Kita-ku, Osaka 530-0001 and the Tokyo office is located at Level 28
Shinagawa Intercity Tower A, 2-15-1 Konan Minato-ku, Tokyo 108-6028. Both
locations are strategically placed to serve major drug development areas and are
connected by the region's bullet train.
INC Research has provided Phase I to IV clinical development services in the
Asia/Pacific region for nearly 20 years , conducting more than a 1,000 studies
across a broad range of therapeutic areas. For more information on INC
Research's clinical trial services and experience in Japan, please call
+81-6-6450 9360 or visit the website.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to us for a complete range of customized Phase I to IV programs in
all therapeutic areas and patient populations. Our Trusted Process® methodology
and therapeutic foresight lead customers to better-informed product development
decisions, while our solid site relationships are a critical success factor in
delivering clinical trial results on time and on budget. INC was ranked "Top
CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site
Relationship Survey. INC Research is headquartered in Raleigh, NC. For more
information, please visit www.incresearch.com or follow us at (at)inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1719617]
Unternehmensinformation / Kurzprofil:
Datum: 29.07.2013 - 22:32 Uhr
Sprache: Deutsch
News-ID 282752
Anzahl Zeichen: 4762
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 179 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Strengthens Asia/Pacific Capabilities Through Two New Offices in Japan"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
